Cargando…

Use of Botulinum Toxin in Treating Rosacea: A Systematic Review

BACKGROUND: Rosacea is a chronic skin disorder characterized by erythema, flushing, telangiectasia, papules and pustules, phymatous changes, and ocular involvement. The aim of this study was to examine all published research articles in which botulinum toxin was used to treat rosacea and to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hanlin, Tang, Keyun, Wang, Yuanzhuo, Fang, Rouyu, Sun, Qiuning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096341/ https://www.ncbi.nlm.nih.gov/pubmed/33958886 http://dx.doi.org/10.2147/CCID.S307013

Ejemplares similares

Rosacea Treatment: Review and Update
por: Zhang, Hanlin, et al.
Publicado: (2020)

Research Interest and Public Interest in Melanoma: A Bibliometric and Google Trends Analysis
por: Zhang, Hanlin, et al.
Publicado: (2021)

Inpatient Dermatology Consultations in a General Surgery Ward in a Tertiary Hospital in China: A Retrospective Study of 251 Patients
por: Zhang, Hanlin, et al.
Publicado: (2021)

Circular RNA as a Potential Biomarker for Melanoma: A Systematic Review
por: Tang, Keyun, et al.
Publicado: (2021)

The Relationship Between Alzheimer’s Disease and Skin Diseases: A Review
por: Zhang, Hanlin, et al.
Publicado: (2021)

Stigmatization in Patients With Psoriasis: A Mini Review
por: Zhang, Hanlin, et al.
Publicado: (2021)

Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea
por: Yang, Rongli, et al.
Publicado: (2022)

A Particular Bicentric Structure in Dermoscopic Demonstration of Degos Disease
por: Li, Anqi, et al.
Publicado: (2022)

Correction to: Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea
por: Yang, Rongli, et al.
Publicado: (2022)

A Pilot Study to Evaluate the Efficacy and Safety of Treatment with Botulinum Toxin in Patients with Recalcitrant and Persistent Erythematotelangiectatic Rosacea
por: Park, Kui Young, et al.
Publicado: (2018)

Willingness-to-Pay and Benefit–Cost Analysis of Botulinum Toxin for the Treatment of Rosacea in China: Findings from a Web-Based Survey
por: Yang, Xizhao, et al.
Publicado: (2021)

Role of Botulinum Toxin in the Management of Topical Corticosteroid Induced Rosacea Like Dermatitis: A Case Report
por: Katoch, Saloni, et al.
Publicado: (2022)

Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection
por: Mor, Niv, et al.
Publicado: (2015)

Botulinum as a Toxin for Treating Post-herpetic Neuralgia
por: DING, Xu-Dong, et al.
Publicado: (2017)

Effectiveness of the Botulinum Toxin for Treating Sialorrhea in Patients with Parkinson’s Disease: A Systematic Review
por: Ruiz-Roca, Juan Antonio, et al.
Publicado: (2019)

Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review
por: Val, Matteo, et al.
Publicado: (2023)

Efficacy of botulinum toxin in the treatment of bruxism: Systematic review
por: Fernández-Núñez, Tania, et al.
Publicado: (2019)

The Use of Botulinum Toxin in the Management of Hidradenitis Suppurativa: A Systematic Review
por: Geoghegan, Luke, et al.
Publicado: (2022)

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Botulin Toxin Use in Rosacea and Facial Flushing Treatment
por: Scala, Jacopo, et al.
Publicado: (2019)

The Multispecialty Toxin: A Literature Review of Botulinum Toxin
por: Bach, Karen, et al.
Publicado: (2022)

The role of botulinum toxin A in treating neurogenic bladder
por: Weckx, Filip, et al.
Publicado: (2016)

Efficacy of Botulinum Toxin for Treating Sialorrhea in Neuromuscular Conditions
por: Singh, Harsh, et al.
Publicado: (2020)

Dupuytren’s contracture treated with botulinum toxin A injection
por: Davis, Shane Michael, et al.
Publicado: (2021)

Botulinum toxin-A for the treatment of neuralgia: a systematic review and meta-analysis
por: Meng, Fan, et al.
Publicado: (2018)

Use of Botulinum Toxin A to Treat Chemotherapy-Induced Raynaud’s Phenomenon
por: Potluri, Thrisha K, et al.
Publicado: (2021)

Safety and efficacy of botulinum toxin type A in preventing and treating scars in animal models: A systematic review and meta‐analysis
por: Pan, Lingfeng, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Advanced Acral Melanoma: A Systematic Review
por: Zheng, Qingyue, et al.
Publicado: (2020)

Microdroplet Botulinum Toxin: A Review
por: Kandhari, Rajat, et al.
Publicado: (2022)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Immunogenicity of botulinum toxins
por: Naumann, Markus, et al.
Publicado: (2012)

Diffusion of Botulinum Toxins
por: Brodsky, Matthew A., et al.
Publicado: (2012)

Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022)

Therapeutic Use of Botulinum Toxin in Neurorehabilitation
por: Intiso, Domenico
Publicado: (2012)

Use of botulinum toxin in musculoskeletal pain
por: Singh, Jasvinder A
Publicado: (2013)

Use of botulinum toxin in Frey's syndrome
por: Freni, Francesco, et al.
Publicado: (2019)

Use of botulinum toxin for movement disorders
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2019)

Use of botulinum toxin for voiding dysfunction
por: Eldred-Evans, David, et al.
Publicado: (2017)

Physical Exercises in Combination with Botulinum Toxin in Treating Children with Cerebral Palsy: A Literature Review
por: Sharma, Abhishek, et al.
Publicado: (2022)

Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review
por: Żebryk, Paweł, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_khdhbl4iu6b0g5ftr397q28qn0